世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034733

急性骨髄性白血病の世界市場レポート(2023年)

The Business Research Company

Acute Myeloid Leukemia Global Market Report 2023

発刊日 2023/04/06

言語英語

体裁PDF、Word、Excel データ ダッシュボード/200ページ

ライセンス/価格200ページ

0000034733

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、戦略担当者、マーケティング担当者、経営幹部に、世界の急性骨髄性白血病市場を評価するために必要な重要な情報を提供します。

本レポートは、力強い成長を経験している急性骨髄性白血病市場に焦点を当てています。本 レポートは、今後10年以上にわたって私たちの生活を形作り変化させる急性骨髄性白血病市場へのガイドを提供します。

調査範囲

  • 調査市場
    ➣ 治療タイプ別
      ◇ 化学療法
      ◇ 放射線治療
      ◇ 幹細胞移植
      ◇ 標的療法
    ➣ 化学療法別
      ◇ シタラビン
      ◇ アントラサイクリン系薬剤
      ◇ アルキル化剤
      ◇ 代謝拮抗薬
      ◇ チロシンキナーゼ阻害薬
      ◇ ホルモン療法
    ➣ 治療方式別
      ◇ DC療法
      ◇ AVD療法
      ◇ VCD療法
    ➣ エンドユーザー別
      ◇ 病院
      ◇ 小売薬局
      ◇ 外来診療センター
      ◇ 診療所
  • 調査企業
    ➣ Pfizer Inc.
    ➣ Novartis AG
    ➣ Sanofi-Aventis (Genzyme Corporation)
    ➣ Bristol Myers Squibb
    ➣ Amgen Inc.
  • 調査国
    ➣ オーストラリア
    ➣ ブラジル
    ➣ 中国
    ➣ フランス
    ➣ ドイツ
    ➣ インド
    ➣ インドネシア
    ➣ 日本
    ➣ ロシア
    ➣ 韓国
    ➣ イギリス
    ➣ アメリカ
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。
  • 提供形式
    ➣ PDF
    ➣ Word
    ➣ Excel データダッシュボード

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Acute Myeloid Leukemia Market Characteristics

3. Acute Myeloid Leukemia Market Trends And Strategies

4. Acute Myeloid Leukemia Market - Macro Economic Scenario
4.1 COVID-19 Impact On Acute Myeloid Leukemia Market
4.2 Ukraine-Russia War Impact On Acute Myeloid Leukemia Market
4.3 Impact Of High Inflation On Acute Myeloid Leukemia Market

5. Acute Myeloid Leukemia Market Size And Growth
5.1. Global Acute Myeloid Leukemia Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Acute Myeloid Leukemia Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Acute Myeloid Leukemia Market Segmentation
6.1. Global Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Chemotherapy
Radiation therapy
Stem Cell Transplant
Targeted Therapy
6.2. Global Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Cytarabine
Anthracycline Drugs
Alkylating Agents
Anti-metabolites
Tyrosine Kinase Inhibitors
Hormonal Therapy
6.3. Global Acute Myeloid Leukemia Market, Segmentation By Regimen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
DC Regimen
AVD Regimen
VCD Regimen
6.4. Global Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospital
Retails Drug Stores
Ambulatory Care Centers
Clinics

7. Acute Myeloid Leukemia Market Regional And Country Analysis
7.1. Global Acute Myeloid Leukemia Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Acute Myeloid Leukemia Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Acute Myeloid Leukemia Market
8.1. Asia-Pacific Acute Myeloid Leukemia Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Acute Myeloid Leukemia Market
9.1. China Acute Myeloid Leukemia Market Overview
9.2. China Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Acute Myeloid Leukemia Market
10.1. India Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Acute Myeloid Leukemia Market
11.1. Japan Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Acute Myeloid Leukemia Market
12.1. Australia Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Acute Myeloid Leukemia Market
13.1. Indonesia Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Acute Myeloid Leukemia Market
14.1. South Korea Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Acute Myeloid Leukemia Market
15.1. Western Europe Acute Myeloid Leukemia Market Overview
15.2. Western Europe Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Acute Myeloid Leukemia Market
16.1. UK Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Acute Myeloid Leukemia Market
17.1. Germany Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Acute Myeloid Leukemia Market
18.1. France Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Acute Myeloid Leukemia Market
19.1. Eastern Europe Acute Myeloid Leukemia Market Overview
19.2. Eastern Europe Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Acute Myeloid Leukemia Market
20.1. Russia Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Acute Myeloid Leukemia Market
21.1. North America Acute Myeloid Leukemia Market Overview
21.2. North America Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Acute Myeloid Leukemia Market
22.1. USA Acute Myeloid Leukemia Market Overview
22.2. USA Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Acute Myeloid Leukemia Market
23.1. South America Acute Myeloid Leukemia Market Overview
23.2. South America Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Acute Myeloid Leukemia Market
24.1. Brazil Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Acute Myeloid Leukemia Market
25.1. Middle East Acute Myeloid Leukemia Market Overview
25.2. Middle East Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Acute Myeloid Leukemia Market
26.1. Africa Acute Myeloid Leukemia Market Overview
26.2. Africa Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Acute Myeloid Leukemia Market Competitive Landscape And Company Profiles
27.1. Acute Myeloid Leukemia Market Competitive Landscape
27.2. Acute Myeloid Leukemia Market Company Profiles
27.2.1. Pfizer Inc.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Novartis AG
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Sanofi-Aventis (Genzyme Corporation)
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Bristol Myers Squibb
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Amgen Inc.
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Acute Myeloid Leukemia Market

29. Acute Myeloid Leukemia Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. The Business Research Company
30.6. Copyright And Disclaimer

この商品のレポートナンバー

0000034733

TOP